About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medicines Information
Adverse Drug Reactions
Clinical guidelines
Compliance
Drug Alerts
Drug Interactions
Drug reviews
Drug shortages
Drugs in lactation
Drugs in liver disease
Drugs in paediatrics
Drugs in pregnancy
Drugs in renal failure
FAQs
General Advice
Horizon scanning
Medication errors
Pharmaceutical Industry
Pharmaceutics
Product Discontinuation
Product Licence Changes
Toxicology & poisoning
Travel health
Unlicenced medicines
Licence extension
New drugs
545 library items
in Licence extension
Filter results by:
Date Published
2012 (10)
2011 (111)
2010 (89)
2009 (111)
2008 (88)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Horizon scanning (
remove
)
,
Licence extension (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 545
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
FDA to discuss license extension application for denosumab (Xgeva) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases
Source:
BioSpace
,
Date published:
09/02/2012
Category:
Cancer: prostate
|
Food &Drug Administration (FDA)
|
Licence extension
|
Rheumatology
NeLM
Area:
News
Link
2.
Horizon scanning: FDA approves Vyvanse™ (lisdexamfetamine dimesylate) for maintenance of ADHD in adults
Source:
BioSpace
,
Date published:
08/02/2012
Category:
4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder
|
Attention deficit / hyperactivity disorder
|
Food &Drug Administration (FDA)
|
Licence extension
NeLM
Area:
News
Link
3.
Horizon scanning: FDA approves Sklice™ (ivermectin) Lotion for the treatment of head lice
Source:
PharmaLive
,
Date published:
08/02/2012
Category:
13.10.3 Antiviral preparations
|
Food &Drug Administration (FDA)
|
Licence extension
|
Parasitic
NeLM
Area:
News
Link
4.
Horizon scanning: FDA Grants priority review of pertuzumab for untreated HER2-Positive metastatic breast cancer
Source:
BioSpace
,
Date published:
08/02/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: breast
|
Food &Drug Administration (FDA)
|
Licence extension
NeLM
Area:
News
Link
5.
Vildagliptin (Galvus®) approved for use as monotherapy in the EU
Source:
PharmaLive
,
Date published:
07/02/2012
Category:
6.1.2 Antidiabetic drugs
|
Diabetes
|
Licence extension
NeLM
Area:
News
Link
6.
Bevacizumab (Avastin®) approved in the EU for ovarian cancer
Source:
Personal communication (Roche)
,
Date published:
23/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: gynaecological
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Licence extension
NeLM
Area:
News
PharmaTimes report (free registration required)
7.
European CHMP issues positive opinion on license extension of infliximab to include paediatric ulcerative colitis
Source:
EMA
,
Date published:
20/01/2012
Category:
1.5.3 Drugs affecting the immune response
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Inflammatory bowel disease
|
Licence extension
|
Paediatrics
NeLM
Area:
News
Link
8.
European CHMP issues positive opinion on wider age range for rotavirus vaccine (Rotateq)
Source:
EMA
,
Date published:
20/01/2012
Category:
14.4 Vaccines and antisera
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Infection
|
Licence extension
|
Vaccination
NeLM
Area:
News
Link
9.
FDA approves Viread® (tenofovir disoproxil fumarate) oral powder for use in children with HIV
Source:
BioSpace
,
Date published:
20/01/2012
Category:
5.3.1 HIV infection
|
Children (2-11 years)
|
Food &Drug Administration (FDA)
|
HIV Infection/AIDS
|
Licence extension
NeLM
Area:
News
Link
10.
FDA approves license extension of Berinert® (C1 Esterase Inhibitor) for self-administration and treatment of acute laryngeal attacks of hereditary angioedema
Source:
PharmaLive
,
Date published:
05/01/2012
Category:
3.4.3 Allergic emergencies
|
Allergy
|
Ear, Nose and Throat (ENT) disorders
|
Emergency Medicine
|
Food &Drug Administration (FDA)
|
Licence extension
NeLM
Area:
News
Link
Results 1 - 10 of 545
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next